Overview Financials News + Filings Key Docs Charts Ownership
|
|
Intellipharmaceutics International Inc. (IPCI)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions of CAD, except per share items | Nov-30-21 | Nov-30-20 | Nov-30-19 | Nov-30-18 | Nov-30-17 | Nov-30-16 | Nov-30-15 | Nov-30-14 |
| | S-1/A | S-1/A | S-1/A | 20-F | 20-F | S-1/A | 20-F | 20-F |
| Assets |
| Cash and equivalents | 0.8 | 0.2 | 0.1 | 6.6 | 1.9 | 4.1 | 1.8 | 4.2 |
| Accounts receivable, net | | 0.6 | 0.2 | 0.2 | 0.7 | 0.5 | 0.5 | 1.0 |
| Inventories | | 0.1 | 0.3 | 0.3 | 0.1 | | | |
| Other current assets | 0.3 | 0.6 | 0.9 | 1.6 | 0.9 | 1.1 | 0.7 | 0.7 |
| Total current assets | 1.1 | 1.5 | 1.5 | 8.7 | 3.6 | 5.7 | 2.9 | 6.0 |
| Property, plant, and equipment, net | 1.0 | 1.8 | 2.3 | 2.8 | 3.3 | 1.9 | 1.8 | 1.6 |
| Total assets | 2.1 | 3.4 | 3.8 | 11.5 | 7.4 | 8.0 | 5.2 | 7.9 |
| |
| Accounts payable | 3.8 | 4.1 | 3.8 | 2.6 | 2.1 | 0.8 | 3.0 | 0.7 |
| Accrued expenses | 2.4 | 1.8 | 1.1 | 0.5 | 0.8 | 1.2 | 0.5 | 0.7 |
| Current portion of long-term debt | 0.2 | 0.2 | 1.7 | 1.8 | 1.3 | 1.5 | 1.5 | 1.4 |
| Current portion of long-term debt | 0.2 | 0.2 | 1.7 | 1.8 | 1.3 | 1.5 | 1.5 | 1.4 |
| Deferred revenues | | | | 0.3 | 0.3 | 0.5 | | |
| Other current liabilities | 1.8 | 1.8 | 0.9 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Total current liabilities | 8.1 | 7.9 | 7.5 | 5.3 | 4.6 | 4.2 | 5.2 | 2.9 |
| Long-term debt | 1.8 | 1.8 | 1.7 | 1.8 | 1.3 | 1.5 | 0.0 | 0.0 |
| Other liabilities | 0.4 | 0.0 | | 0.3 | 1.1 | 1.2 | 0.2 | |
| Total liabilities | 10.3 | 9.7 | 9.2 | 7.4 | 7.0 | 6.9 | 5.4 | 3.0 |
| |
| Shareholders' equity [+] | -8.2 | -6.3 | -5.4 | 4.1 | 0.4 | 1.1 | -0.1 | 4.9 |
| Paid-in capital | 44.6 | 44.4 | 44.2 | 45.1 | 36.7 | 34.0 | 31.0 | 31.1 |
| Retained earnings | -102.2 | -97.1 | -93.7 | -85.6 | -71.9 | -63.0 | -52.9 | -45.4 |
| Tangible shareholders' equity | -8.2 | -6.3 | -5.4 | 4.1 | 0.4 | 1.1 | -0.1 | 4.9 |
|